Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Everest Medicines Limited
  6. News
  7. Press Releases
    1952   KYG3224E1061

EVEREST MEDICINES LIMITED

(1952)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société EVEREST MEDICINES LIMITED
01/11Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy in Combi..
AQ
2021Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China..
PR
2021Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program
PR
2021Everest Medicines Announces Share Repurchase Transaction Details
PR
2021EVEREST MEDICINES : Initiates Submission of New Drug Application in Hong Kong for XeravaTM..
PR
2021EVEREST MEDICINES : Announces Approval of Investigational New Drug Application by China NM..
PR
2021EVEREST MEDICINES : Providence Therapeutics And Everest Medicines Enter Into Comprehensive..
AQ
2021EVEREST MEDICINES : Sinovent and SinoMab Announce Licensing Agreement for Global Developme..
PR
2021EVEREST MEDICINES : Enters into Comprehensive Agreements with Providence Therapeutics to A..
PR
2021EVEREST MEDICINES : Announces Up to HK$100 million Share Repurchase Program
PR
2021EVEREST MEDICINES : Announces Half-Year 2021 Interim Results
PR
2021EVEREST MEDICINES : Announces Strategic Commercial Partnership with Global Technology Comp..
PR
2021EVEREST MEDICINES : Monthly Return of Equity Issuer on Movements in Securities for the mon..
PU
2021EVEREST MEDICINES : Voluntary announcement business update on receiving orphan drug design..
PU
2021EVEREST MEDICINES : Form of Proxy for the Annual General Meeting to be held on Tuesday, 1 ..
PU
2021CIRCULAR RE : Proposed Re-election of Directors and Proposed Granting of General Mandates ..
PU
2021EVEREST MEDICINES : Voluntary announcement - appointment of chief scientific officer
PU
2021EVEREST MEDICINES : Announces that the US FDA has Granted Licensing Partner Gilead Science..
PR
2021EVEREST MEDICINES : Voluntary announcement business update on us fda granting licensing pa..
PU
2021EVEREST MEDICINES : Monthly Return of Equity Issuer on Movements in Securities for the mon..
PU
2021EVEREST MEDICINES : Announces that Licensing Partner Gilead Sciences, Inc. has Received Fu..
PR
2021EVEREST MEDICINES : Voluntary announcement business update on licensing partner gilead sci..
PU
2021EVEREST MEDICINES : Voluntary announcement business update on china nmpa approval of clini..
PU
2021EVEREST MEDICINES : Announces Financial Results for Full Year Ended December 31, 2020
PR
2021EVEREST MEDICINES : Announces Acceptance of New Drug Application by China NMPA for Xerava&..
PR
2021EVEREST MEDICINES : Voluntary announcement-business update on acceptance of new drug appli..
PU
2021EVEREST MEDICINES : Announces Selection as a Constituent of Certain Indexes of Hang Seng I..
PR
2021EVEREST MEDICINES : Voluntary announcement-selection as a constituent of certain indexes o..
PU
Upcoming event on EVEREST MEDICINES LIMITED